GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,000 | -96.7% | 65 | -95.7% | 0.00% | -100.0% |
| Q2 2021 | $60,000 | +87.5% | 1,505 | +65.2% | 0.01% | +66.7% |
| Q1 2021 | $32,000 | +10.3% | 911 | +13.2% | 0.01% | 0.0% |
| Q4 2020 | $29,000 | +20.8% | 805 | +23.5% | 0.01% | +20.0% |
| Q3 2020 | $24,000 | -38.5% | 652 | -31.2% | 0.01% | -37.5% |
| Q2 2020 | $39,000 | +25.8% | 947 | +13.8% | 0.01% | 0.0% |
| Q1 2020 | $31,000 | -39.2% | 832 | -23.7% | 0.01% | -27.3% |
| Q4 2019 | $51,000 | +15.9% | 1,091 | +3.2% | 0.01% | +10.0% |
| Q3 2019 | $44,000 | +18.9% | 1,057 | +12.8% | 0.01% | +25.0% |
| Q2 2019 | $37,000 | -5.1% | 937 | +1.3% | 0.01% | -11.1% |
| Q1 2019 | $39,000 | -2.5% | 925 | -11.7% | 0.01% | -64.0% |
| Q4 2018 | $40,000 | -9.1% | 1,048 | -5.3% | 0.02% | +8.7% |
| Q3 2018 | $44,000 | -17.0% | 1,107 | -15.6% | 0.02% | -14.8% |
| Q2 2018 | $53,000 | +3.9% | 1,311 | 0.0% | 0.03% | +3.8% |
| Q1 2018 | $51,000 | +30.8% | 1,311 | +17.8% | 0.03% | +36.8% |
| Q4 2017 | $39,000 | -18.8% | 1,113 | -5.6% | 0.02% | -20.8% |
| Q3 2017 | $48,000 | +11.6% | 1,179 | +17.7% | 0.02% | +14.3% |
| Q2 2017 | $43,000 | +2.4% | 1,002 | 0.0% | 0.02% | 0.0% |
| Q1 2017 | $42,000 | 0.0% | 1,002 | -9.2% | 0.02% | 0.0% |
| Q4 2016 | $42,000 | -34.4% | 1,103 | -25.1% | 0.02% | -41.7% |
| Q3 2016 | $64,000 | 0.0% | 1,473 | 0.0% | 0.04% | -5.3% |
| Q2 2016 | $64,000 | +6.7% | 1,473 | 0.0% | 0.04% | +5.6% |
| Q1 2016 | $60,000 | +22.4% | 1,473 | +22.1% | 0.04% | +24.1% |
| Q4 2015 | $49,000 | -3.9% | 1,206 | -9.0% | 0.03% | -12.1% |
| Q3 2015 | $51,000 | +18.6% | 1,325 | +28.0% | 0.03% | +32.0% |
| Q2 2015 | $43,000 | -30.6% | 1,035 | -23.2% | 0.02% | -30.6% |
| Q1 2015 | $62,000 | +21.6% | 1,347 | +12.7% | 0.04% | +16.1% |
| Q4 2014 | $51,000 | -16.4% | 1,195 | -10.3% | 0.03% | -20.5% |
| Q3 2014 | $61,000 | -14.1% | 1,332 | 0.0% | 0.04% | -7.1% |
| Q2 2014 | $71,000 | 0.0% | 1,332 | 0.0% | 0.04% | -4.5% |
| Q1 2014 | $71,000 | 0.0% | 1,332 | 0.0% | 0.04% | +7.3% |
| Q4 2013 | $71,000 | +6.0% | 1,332 | 0.0% | 0.04% | -2.4% |
| Q3 2013 | $67,000 | +28.8% | 1,332 | +29.1% | 0.04% | +16.7% |
| Q2 2013 | $52,000 | – | 1,032 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |